【攝護腺癌】《Clarity》將展開「攝護腺癌」的新型「PSMA PET」藥物三期臨床試驗

 【攝護腺癌】《Clarity》將展開「攝護腺癌」的新型「PSMA PET」藥物三期臨床試驗

▌文章出處

 Diagnostic imaging

▌原文標題

 Clarity Pharmaceuticals to Begin Phase 3 Trial for New PSMA PET Agent for Prostate Cancer

▌文章序號

 3832

｜智醫科學－AI醫療技術、應用與市場動態

Copyright ©2023 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.